Neutrophil-to-lymphocyte Ratio is a Predictive Marker for Invasive Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas

被引:101
作者
Gemenetzis, Georgios [1 ]
Bagante, Fabio [1 ]
Griffin, James F. [1 ]
Rezaee, Neda [1 ]
Javed, Ammar A. [1 ]
Manos, Lindsey L. [1 ]
Lennon, Anne M. [2 ]
Wood, Laura D. [3 ]
Hruban, Ralph H. [3 ]
Zheng, Lei [4 ]
Zaheer, Atif [5 ]
Fishman, Elliot K. [5 ]
Ahuja, Nita [1 ]
Cameron, John L. [1 ]
Weiss, Matthew J. [1 ]
He, Jin [1 ]
Wolfgang, Christopher L. [1 ]
机构
[1] Johns Hopkins Med Inst, Dept Surg, Blalock 685,600 North Wolfe St, Baltimore, MD 21287 USA
[2] Johns Hopkins Med Inst, Dept Gastroenterol, Baltimore, MD 21205 USA
[3] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA
[4] Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21205 USA
[5] Johns Hopkins Med Inst, Dept Radiol, Baltimore, MD 21205 USA
关键词
cancer; intraductal papillary mucinous neoplasm; marker; neutrophil-to-lymphocyte; nomogram; pancreatic; predictive; ratio; INTERNATIONAL-CONSENSUS-GUIDELINES; DISEASE-SPECIFIC SURVIVAL; IMMUNE-SYSTEM; NEUTROPHIL/LYMPHOCYTE RATIO; CYSTIC NEOPLASMS; PROGNOSTIC VALUE; CANCER; FEATURES; RISK; PROGRESSION;
D O I
10.1097/SLA.0000000000001988
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: To evaluate the correlation between neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) values, and the presence of invasive carcinoma in patients with intraductal papillary mucinous neoplasm (IPMN). Background: NLR and (PLR) are inflammatory markers that have been associated with overall survival in patients with invasive malignancies, including pancreatic cancer. Methods: We retrospectively reviewed 272 patients who underwent surgical resection for histologically confirmed IPMN from January 1997 to July 2015. NLR and PLR were calculated and coevaluated with additional demographic, clinical, and imaging data for possible correlation with IPMN-associated carcinoma in the form of a predictive nomogram. Results: NLR and PLR were significantly elevated in patients with IPMN-associated invasive carcinoma (P < 0.001). In the multivariate analysis, NLR value higher than 4 (P < 0.001), IPMN cyst of size more than 3 cm (P < 0.001), presence of enhanced solid component (P = 0.014), main pancreatic duct dilatation of more than 5mm(P < 0.001), and jaundice (P < 0.001) were statistically significant variables. The developed statistical model has a c-index of 0.895. Implementation of the statistically significant variables in a predictive nomogram provided a reliable point system for estimating the presence of IPMN-associated invasive carcinoma. Conclusions: NLR is an independent predictive marker for the presence of IPMN-associated invasive carcinoma. Further prospective studies are needed to assess the predictive ability of NLR and how it can be applied in the clinical setting.
引用
收藏
页码:339 / 345
页数:7
相关论文
共 50 条
[1]   Cyst Features and Risk of Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Meta-Analysis [J].
Anand, Neeraj ;
Sampath, Kartik ;
Wu, Bechien U. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (08) :913-921
[2]   The Neutrophil-to-Lymphocyte Ratio Predicts Malignant Potential in Intraductal Papillary Mucinous Neoplasms [J].
Arima, Kota ;
Okabe, Hirohisa ;
Hashimoto, Daisuke ;
Chikamoto, Akira ;
Kuroki, Hideyuki ;
Taki, Katsunobu ;
Kaida, Takayoshi ;
Higashi, Takaaki ;
Nitta, Hidetoshi ;
Komohara, Yoshihiro ;
Beppu, Toru ;
Takeya, Motohiro ;
Baba, Hideo .
JOURNAL OF GASTROINTESTINAL SURGERY, 2015, 19 (12) :2171-2177
[3]   Predictive Value of Neutrophil/Lymphocyte Ratio for Efficacy of Preoperative Chemotherapy in Triple-Negative Breast Cancer [J].
Asano, Yuka ;
Kashiwagi, Shinichiro ;
Onoda, Naoyoshi ;
Noda, Satoru ;
Kawajiri, Hidemi ;
Takashima, Tsutomu ;
Ohsawa, Masahiko ;
Kitagawa, Seiichi ;
Hirakawa, Kosei .
ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (04) :1104-1110
[4]   Immune Suppression by Neutrophils in HIV-1 Infection: Role of PD-L1/PD-1 Pathway [J].
Bowers, Nathan L. ;
Helton, E. Scott ;
Huijbregts, Richard P. H. ;
Goepfert, Paul A. ;
Heath, Sonya L. ;
Hel, Zdenek .
PLOS PATHOGENS, 2014, 10 (03)
[5]   Pancreatic adenocarcinoma pathology: changing "landscape" [J].
Brosens, Lodewijk A. A. ;
Hackeng, Wenzel M. ;
Offerhaus, G. Johan ;
Hruban, Ralph H. ;
Wood, Laura D. .
JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2015, 6 (04) :358-374
[6]   Prognostic role of the neutrophil-to-lymphocyte ratio in pancreatic cancer: a meta-analysis [J].
Cheng, Hao ;
Long, Feiwu ;
Jaiswar, Mukesh ;
Yang, Lie ;
Wang, Cun ;
Zhou, Zongguang .
SCIENTIFIC REPORTS, 2015, 5
[7]   The Clavien-Dindo Classification of Surgical Complications Five-Year Experience [J].
Clavien, Pierre A. ;
Barkun, Jeffrey ;
de Oliveira, Michelle L. ;
Vauthey, Jean Nicolas ;
Dindo, Daniel ;
Schulick, Richard D. ;
de Santibanes, Eduardo ;
Pekolj, Juan ;
Slankamenac, Ksenija ;
Bassi, Claudio ;
Graf, Rolf ;
Vonlanthen, Rene ;
Padbury, Robert ;
Cameron, John L. ;
Makuuchi, Masatoshi .
ANNALS OF SURGERY, 2009, 250 (02) :187-196
[8]   Predicting Dysplasia and Invasive Carcinoma in Intraductal Papillary Mucinous Neoplasms of the Pancreas: Development of a Preoperative Nomogram [J].
Correa-Gallego, Camilo ;
Do, Richard ;
LaFemina, Jennifer ;
Gonen, Mithat ;
D'Angelica, Michael I. ;
DeMatteo, Ronald P. ;
Fong, Yuman ;
Kingham, T. Peter ;
Brennan, Murray F. ;
Jarnagin, William R. ;
Allen, Peter J. .
ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (13) :4348-4355
[9]   Paradoxical roles of the immune system during cancer development [J].
de Visser, KE ;
Eichten, A ;
Coussens, LM .
NATURE REVIEWS CANCER, 2006, 6 (01) :24-37
[10]   Interobserver Agreement for Detection of Malignant Features of Intraductal Papillary Mucinous Neoplasms of the Pancreas on MDCT [J].
Do, Richard K. G. ;
Katz, Seth S. ;
Gollub, Marc J. ;
Li, Jian ;
LaFemina, Jennifer ;
Zabor, Emily C. ;
Moskowitz, Chaya S. ;
Klimstra, David S. ;
Allen, Peter J. .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2014, 203 (05) :973-979